Published in Eur Urol on March 01, 2002
Do new generation flexible ureterorenoscopes offer a higher treatment success than their predecessors? Urol Res (2010) 0.91
Standardized ex vivo comparison of different upper urinary tract biopsy devices: impact on ureterorenoscopes and tissue quality. World J Urol (2012) 0.81
1.2 French stone retrieval baskets further enhance irrigation flow in flexible ureterorenoscopy. Urolithiasis (2013) 0.76
Superiority of the EF-120-00-3F biopsy forceps in the histopathological evaluation of upper urinary tract specimens. World J Urol (2013) 0.75
2007 guideline for the management of ureteral calculi. J Urol (2007) 4.44
2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98
Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol (2007) 2.09
Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int (2005) 1.91
980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol (2007) 1.79
Shock wave technology and application: an update. Eur Urol (2011) 1.77
5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol (2005) 1.50
Physiologic bladder evacuation with selective sacral root stimulation: sinusoidal signal and organ-specific frequency. Neurourol Urodyn (2002) 1.41
Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol (2008) 1.40
Radical cystectomy--often too late? 1987. Eur Urol (2006) 1.38
Unfavorable outcomes of laparoscopic pyeloplasty using barbed sutures: a multi-center experience. World J Urol (2013) 1.37
High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol (2002) 1.33
120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol (2010) 1.29
Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer (2008) 1.27
Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res (2005) 1.22
Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol (2002) 1.21
Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center. J Endourol (2009) 1.18
Three-dimensional laparoscopic imaging improves surgical performance on standardized ex-vivo laparoscopic tasks. J Endourol (2012) 1.17
Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life. J Endourol (2006) 1.15
Diverticular carcinoma of the urinary bladder: diagnosis and treatment problems. A case report. Med Princ Pract (2005) 1.13
Donor-site morbidity in buccal mucosa urethroplasty: lower lip or inner cheek? BJU Int (2005) 1.08
Validation of computer-based training in ureterorenoscopy. BJU Int (2005) 1.08
Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest (2002) 1.05
The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol (2004) 1.04
Flexible ureterorenoscopy for lower pole stones: influence of the collecting system's anatomy. J Endourol (2013) 1.04
Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones. BJU Int (2007) 1.03
A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access. J Endourol (2007) 1.02
Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol (2004) 1.02
Two contemporary series of percutaneous tract dilation for percutaneous nephrolithotomy. J Endourol (2009) 1.02
Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol (2011) 0.99
Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int (2005) 0.99
Live surgical education: a perspective from the surgeons who perform it. BJU Int (2014) 0.97
The past, present and future of minimally invasive therapy in urology: a review and speculative outlook. Minim Invasive Ther Allied Technol (2013) 0.97
Prostate cancer therapy: standard management, new options and experimental approaches. Anticancer Res (2005) 0.96
Risk of collateral damage to endourologic tools by holmium:YAG laser energy. J Endourol (2006) 0.93
Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol (2007) 0.92
Do new generation flexible ureterorenoscopes offer a higher treatment success than their predecessors? Urol Res (2010) 0.91
Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. J Urol (2012) 0.89
The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: tract dilation comparisons in 5537 patients. J Endourol (2011) 0.88
Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int (2006) 0.88
Technical characterization of a new bipolar and multipolar radiofrequency device for minimally invasive treatment of renal tumours. BJU Int (2006) 0.87
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int (2006) 0.87
The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging. BJU Int (2007) 0.87
Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas. BJU Int (2009) 0.87
Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer. Urol Res (2004) 0.86
The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability. World J Urol (2013) 0.86
Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients. Med Princ Pract (2006) 0.86
Conventional high pressure versus newly developed continuous-flow ureterorenoscope: urodynamic pressure evaluation of the renal pelvis and flow capacity. J Endourol (2008) 0.85
Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma. Lasers Med Sci (2004) 0.85
Shock wave lithotripsy: the new phoenix? World J Urol (2014) 0.84
New bipolar resection device for transurethral resection of the prostate: first ex-vivo and in-vivo evaluation. J Endourol (2005) 0.84
Risk of detrusor denervation in antireflux surgery demonstrated in a neurophysiological animal model. J Urol (2003) 0.84
Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer. Oncol Rep (2009) 0.84
The influence of oxalate on renal epithelial and interstitial cells. Urol Res (2004) 0.84
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging. Eur Urol (2005) 0.83
Ureteroscopy for stone treatment using new 270 degrees semiflexible endoscope: in vitro, ex vivo, and clinical application. J Endourol (2007) 0.83
Hemostatic properties of four devices for partial nephrectomy: a comparative ex vivo study. J Endourol (2008) 0.83
Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation. Anticancer Res (2004) 0.82
Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology (2008) 0.81
Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int (2008) 0.81
Initial experience with a newly developed antirefluxive ureter stent. Urol Res (2011) 0.81
Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides. Urol Oncol (2004) 0.81
Percutaneous nephrolithotomy under combined sonographic/radiologic guided puncture: results of a learning curve using the modified Clavien grading system. World J Urol (2013) 0.81
Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol. J Cardiovasc Pharmacol (2003) 0.81
Hans Christian Jacobaeus: Inventor of human laparoscopy and thoracoscopy. J Endourol (2006) 0.81
First clinical evaluation of a new innovative ureteral access sheath (Re-Trace™): a European study. World J Urol (2013) 0.80
Beyond ESWL: new concepts for definitive stone removal. World J Urol (2011) 0.80
[Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents]. Arch Esp Urol (2002) 0.80
Impact of hypoxia and hypercapnia on calcium oxalate toxicity in renal epithelial and interstitial cells. Urol Res (2006) 0.79
Surgical Atlas. Percutaneous nephrolithotomy: the Mannheim technique. BJU Int (2007) 0.79
The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma. BJU Int (2008) 0.79
Multiple high-intensity focused ultrasound probes for kidney-tissue ablation. J Endourol (2005) 0.78
Polytetrafluoroethylene versus polypropylene sutures for Essed-Schroeder tunical plication. J Urol (2003) 0.78